A Study to Evaluate the Pharmacokinetics and Safety of BR3409 and Co-administration of BR3409-1 and BR3409-2 in Healthy Volunteers Under Fed Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 5, 2024

Primary Completion Date

December 7, 2024

Study Completion Date

December 7, 2024

Conditions

Type 2 Diabetes

Interventions

DRUG

BR3409

One tablet administered alone

DRUG

BR3409-1

One tablet administered alone

DRUG

BR3409-2

One tablet administered alone

Trial Locations (1)

Clinical Research Center, H PLUS Yangji Hospital, Seoul